Standard Biotools (LAB) Research & Development (2010 - 2026)

Standard Biotools (LAB) has 17 years of Research & Development data on file, last reported at $2.1 million in Q1 2026.

• Research & Development for Q1 2026 came in at $2.1 million, down 61.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.7 million (down 15.0% YoY), and the FY2025 annual result was $26.0 million, down 9.86% from the prior year.
• Research & Development eased to $2.1 million in Q1 2026 per LAB's latest filing, from $8.0 million in the prior quarter.
• Over five years, Research & Development peaked at $16.0 million in Q1 2024 and troughed at $2.1 million in Q1 2026.
• A 5-year average of $7.6 million and a median of $6.9 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2025: Research & Development soared 148.56% in 2024, then slumped 65.96% in 2025.
• A 5-year view of Research & Development shows it stood at $7.4 million in 2022, then slipped by 6.95% to $6.9 million in 2023, then gained by 1.9% to $7.0 million in 2024, then rose by 13.2% to $8.0 million in 2025, then sank by 73.43% to $2.1 million in 2026.
• Business Quant data shows LAB's Research & Development at $2.1 million in Q1 2026, $8.0 million in Q4 2025, and $6.4 million in Q3 2025.